Related Experiment Videos
Metabolism of ethosuximide
Clinical Pharmacology and Therapeutics
|August 1, 1976
Summary
This study found that giving ethosuximide once daily is as effective as dividing the dose. Ethosuximide plasma levels and urinary excretion were similar, supporting single-dose regimens for patient management and overdosage treatment.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Drug Metabolism
Background:
- Ethosuximide is a common antiepileptic drug.
- Optimal dosing regimens are crucial for therapeutic efficacy and patient adherence.
- Understanding ethosuximide pharmacokinetics is essential for effective treatment.
Purpose of the Study:
- To compare the pharmacokinetic profiles of once-daily versus three-times-daily dosing of ethosuximide.
- To evaluate the impact of dose division on steady-state plasma levels and urinary excretion of ethosuximide.
Main Methods:
- Double-blind, controlled, rising dose study.
- Twenty subjects received ethosuximide.
- Plasma levels and urinary throughput were measured.
Main Results:
- Steady-state plasma levels of ethosuximide were dose-proportional.
- Urinary throughput was dose-proportional.
- Plasma levels and urinary excretion were equivalent between once-daily and three-times-daily dosing regimens.
Conclusions:
- A single daily dose regimen for ethosuximide is a viable therapeutic option.
- Findings support the consideration of once-daily ethosuximide for improved patient management.
- Metabolic principles should guide ethosuximide dosing and overdosage treatment.